Zhiqi Feng
Family Medicine · Las Vegas, NVNPI 1093205510
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,396 of the $11,601 with a category attached, or 81.0%. It is spread thinly across 43 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 353 payments — averaging $32.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Gilead$1K
- Biohaven Pharmaceuticals, Inc.$1K
- Scynexis, Inc.$1K
- Novo Nordisk$846
- Bayer$821
- plus $5K from 37 others
What the payments were for
- Consulting fees$2,20019%
- Food & beverage$9,39681%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,601 in reported general payments places this provider in the 95th percentile of 902 family medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 137 | $125,450 |
| JardianceEmpagliflozin | 111 | $105,032 |
| EliquisApixaban | 122 | $54,560 |
| VascepaIcosapent Ethyl | 82 | $53,167 |
| JanuviaSitagliptin Phosphate | 30 | $45,239 |
| ProliaDenosumab | 20 | $34,168 |
| OzempicSemaglutide | 23 | $28,221 |
| XareltoRivaroxaban | 39 | $24,858 |
| VemlidyTenofovir Alafenamide | 16 | $22,627 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $21,265 |
| MyrbetriqMirabegron | 47 | $18,402 |
| Diclofenac Epolamine | 27 | $17,187 |
| TradjentaLinagliptin | 16 | $16,525 |
| LinzessLinaclotide | 25 | $16,478 |
| DapagliflozinDapagliflozin Propanediol | 26 | $11,271 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $1,571 | $146,715162 claims |
| Boehringer IngelheimJardiance, Tradjenta | $519 | $121,557127 claims |
| PfizerEliquis | $169 | $54,560122 claims |
| MerckJanuvia | $16 | $45,23930 claims |
| AmgenProlia, Corlanor | $618 | $38,66137 claims |
| Novo NordiskOzempic | $846 | $28,22123 claims |
| GileadVemlidy | $1,360 | $22,62716 claims |
| Astellas Pharma US IncMyrbetriq | $125 | $18,40247 claims |
| AbbVieLinzess | $212 | $16,47825 claims |
| GSKBreo Ellipta, Anoro Ellipta | $226 | $15,87030 claims |
| NovartisEntresto | $95 | $11,01123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 902 family medicine providers in Nevada.
Other family medicine in Las Vegas
- Naz WahabLas Vegas$563K
- Jerry CadeLas Vegas$180K
- Nilesh GokalLas Vegas$75K
- Warren MagnusLas Vegas$70K
- Kimberly AdamsLas Vegas$51K
- Mandeep GillLas Vegas$24K
- Francis JimenezLas Vegas$20K
- Ryan HuangLas Vegas$18K
- Ma Francesca ChamianLas Vegas$17K
- Leo CapobiancoLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.